Serial, non-invasive molecular analysis of exhaled breath condensate to define the pulmonary flora in critically injured, ventilated adults

NIH RePORTER · NIH · R01 · $150,146 · view on reporter.nih.gov ↗

Abstract

DESCRIPTION (provided by applicant): This is an innovative proposal to determine the capacity of molecular analysis of exhaled breath condensate filters (EBCF) to predict ventilator associated pneumonia (VAP) in trauma intensive care unit patients. Based upon preliminary data of 51 patients suspected of having VAP, who underwent bronchoalveolar lavage, we have previously demonstrated a strong correlation between bronchoalveolar lavage and breath condensate quantitative PCR. The goal of this proposal is to understand the changes that occur in the pulmonary microbial community of mechanically ventilated, critically injured adults to support the development of molecular analysis of EBCF to provide an earlier, more sensitive and specific diagnosis of VAP, to enable: 1) earlier recognition of a developing pneumonia, 2) targeted antimicrobial therapy, and 3) assessment of treatment response.

Key facts

NIH application ID
10132066
Project number
3R01GM115353-04S1
Recipient
VANDERBILT UNIVERSITY MEDICAL CENTER
Principal Investigator
Wonder P. Drake
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$150,146
Award type
3
Project period
2015-07-15 → 2021-04-30